The University of Michigan, along with Michigan Medicine, announced Monday that they will no longer provide gender-affirming care –– including puberty blockers and hormone therapies –– for individuals younger than 19, citing a federal criminal and civil investigation against the institution.

In an email to The Michigan Daily, Mary Masson, director of public relations at Michigan Medicine, confirmed the ban.

“At this time, we will be discontinuing these therapies for all individuals under the age of 19,” Masson wrote.

The shift comes as gender-affirming care has become the subject of nationwide legal battles following an executive order signed by President Donald Trump in January restricting such treatments for minors. The Trump administration also cut federal grants supporting t

See Full Page